Why axing TPP was a lost opportunity for biotech

Nat Biotechnol. 2017 Mar 7;35(3):206-207. doi: 10.1038/nbt.3821.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biotechnology / economics
  • Biotechnology / legislation & jurisprudence*
  • Humans
  • International Cooperation / legislation & jurisprudence*
  • Public Policy / economics
  • Public Policy / legislation & jurisprudence*
  • United States